FdaApplication

NDA 019977

Back to search

Identifiers

Properties

PropertyValue
applicant_nameXANODYNE PHARMACEUTICALS INC
application_typeNDA
approval_date1991-08-15

Products (4)

ProductActive ingredientStrengthDosage form
ORAMORPH SRMORPHINE SULFATE30MGTABLET, EXTENDED RELEASE;ORAL
ORAMORPH SRMORPHINE SULFATE15MGTABLET, EXTENDED RELEASE;ORAL
ORAMORPH SRMORPHINE SULFATE60MGTABLET, EXTENDED RELEASE;ORAL
ORAMORPH SRMORPHINE SULFATE100MGTABLET, EXTENDED RELEASE;ORAL

4 products